Stay updated on Filgotinib in Active Noninfectious Uveitis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in Active Noninfectious Uveitis Clinical Trial page.

Latest updates to the Filgotinib in Active Noninfectious Uveitis Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notices (v3.4.1), which are minor metadata updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a government funding lapse and the NIH Clinical Center's status, and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe glossary is now shown and minor text updates were made to QC labeling and FEAR Act wording, with the page revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations section updated: new locations were added (California, Colorado, Illinois, Massachusetts, Michigan, New Jersey, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Wisconsin, Western Australia). Existing location entries were removed, and the revision label updated from v3.3.2 to v3.3.3.SummaryDifference1%

Stay in the know with updates to Filgotinib in Active Noninfectious Uveitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in Active Noninfectious Uveitis Clinical Trial page.